Experts consensus on epidemic prevention and control in radiotherapy centers during the COVID-19 outbreak: Experiences from Sichuan Province.

COVID-19 Consensus Epidemic prevention and control Radiotherapy Radiotherapy center

Journal

Clinical and translational radiation oncology
ISSN: 2405-6308
Titre abrégé: Clin Transl Radiat Oncol
Pays: Ireland
ID NLM: 101713416

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 08 04 2020
revised: 25 04 2020
accepted: 21 06 2020
entrez: 16 7 2020
pubmed: 16 7 2020
medline: 16 7 2020
Statut: epublish

Résumé

After the outbreak of COVID-19, medical institutions in China and even around the world are facing unprecedented challenges. In order to minimize the adverse impact of this unexpected epidemic on patients who need radiotherapy, the expert group of our radiotherapy center immediately formulated comprehensive emergency plans and prevention and control measures, partitioned the work area, launched online staff training, and optimized the radiotherapy process after the outbreak, which provided a strong guarantee for the safe and orderly operation of our radiotherapy center and kept the infection rate to an extremely low level. We hope our experience could provide reference and suggestions for other medical institutions.

Identifiants

pubmed: 32665983
doi: 10.1016/j.ctro.2020.06.010
pii: S2405-6308(20)30059-8
pmc: PMC7324327
doi:

Types de publication

Journal Article

Langues

eng

Pagination

88-91

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Radiother Oncol. 2014 Jul;112(1):140-4
pubmed: 24833561
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143

Auteurs

Dekang Zhang (D)

Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Sichuan Key Laboratory of Radiation Oncology, Chengdu, China.
Sichuan Anti-Cancer Association, Chengdu, China.

Tao Li (T)

Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Sichuan Key Laboratory of Radiation Oncology, Chengdu, China.
Sichuan Anti-Cancer Association, Chengdu, China.

Pei Wang (P)

Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Sichuan Key Laboratory of Radiation Oncology, Chengdu, China.
Sichuan Anti-Cancer Association, Chengdu, China.

Weidong Wang (W)

Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Sichuan Key Laboratory of Radiation Oncology, Chengdu, China.
Sichuan Anti-Cancer Association, Chengdu, China.

Mei Feng (M)

Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Sichuan Key Laboratory of Radiation Oncology, Chengdu, China.
Sichuan Anti-Cancer Association, Chengdu, China.

Lintao Li (L)

Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Sichuan Key Laboratory of Radiation Oncology, Chengdu, China.
Sichuan Anti-Cancer Association, Chengdu, China.

Qinghua Jiang (Q)

Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Sichuan Key Laboratory of Radiation Oncology, Chengdu, China.

Mei Lan (M)

Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Sichuan Key Laboratory of Radiation Oncology, Chengdu, China.
Sichuan Anti-Cancer Association, Chengdu, China.

Lucia Clara Orlandini (LC)

Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Sichuan Key Laboratory of Radiation Oncology, Chengdu, China.

Jie Li (J)

Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Sichuan Key Laboratory of Radiation Oncology, Chengdu, China.
Sichuan Anti-Cancer Association, Chengdu, China.

Jinyi Lang (J)

Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Sichuan Key Laboratory of Radiation Oncology, Chengdu, China.
Sichuan Anti-Cancer Association, Chengdu, China.

Classifications MeSH